Foley Catheters Market

The Foley catheters market is projected to reach USD 1,205.0 million by 2030 from USD 931.0 million in 2025, at a CAGR of 5.3% from 2025 to 2030.

The Foley catheters market is currently experiencing growth due to increasing patient demands and the advancement of healthcare facilities. The rising incidence of urinary incontinence, urological conditions, and diseases such as kidney, bladder, and prostate disorders is driving consistent demand for catheterization. Additionally, the aging global population, which is more prone to these health issues, is further contributing to market growth.

To know about the assumptions considered for the study download the pdf brochure

Various market players are implementing different strategies, including product launches, strategic partnerships, and expansions, to strengthen their positions in the Foley catheters market. For example, in July 2025, Amsino International, Inc. (US) launched new AMSure Foley Catheter Trays, which feature a dual antiseptic skin preparation, updated SteriGuide Instructions for Use (IFU), and the Bedal flexGRIP Securement Device to enhance patient safety and catheter stability. In January 2023, Bactiguard AB (US) received approval under the Medical Device Regulation (EU) 2017/745 for its Latex BIP Foley Catheter, which includes the company’s proprietary infection prevention coating.

Prominent players in the market include Coloplast A/S (Denmark), Becton, Dickinson and Company (US), Cardinal Health, Inc. (US), Teleflex Incorporated (US), Medtronic Plc (Ireland), Sterimed Group (India), Medline Industries, LP (US), Amsino International, Inc. (US), B. Braun SE (Germany), Bactiguard AB (US), and McKesson Corporation (US).

Coloplast A/S (Denmark), operating within the Interventional Urology sector, had a strong performance in the 2023/24 financial year, achieving 5% organic sales growth. The revenue for this business increased by 4% year-over-year, reaching approximately USD 402.7 million (DKK 2,775 million). In November 2023, Coloplast demonstrated its commitment to long-term growth and supply chain optimization by investing about USD 105 million (DKK 700 million) to establish a new production facility in Portugal. This strategic move aims to enhance production capacity, meet the rising global demand for Foley catheters, and strengthen Coloplast's competitive position in the market.

Becton, Dickinson and Company (US) is a prominent player in the global Foley catheters market. In 2024, its Urology and Critical Care segment generated USD 1,554 million in revenue. BD's growth strategy focuses on product innovation, expanding its geographic reach, and forming strategic partnerships. A significant development in this area was BD's exclusive global licensing agreement with Bactiguard in 2023, which grants BD access to Bactiguard-coated Foley catheters worldwide, except for China. This agreement greatly enhances BD's infection-prevention portfolio. BD invested USD 4,857 million in research & development in 2024, demonstrating its commitment to advancing catheter technology. This investment aims to create next-generation solutions, including improved catheter designs and smart monitoring systems.

Teleflex Incorporated (US) is reinforcing its position in the Foley catheters market by focusing on clinical innovation, quality, and sustainability. In 2023, the company invested over USD 8.5 million in clinical research grants, demonstrating its commitment to expanding its portfolio and promoting innovation through targeted mergers and acquisitions in key therapeutic areas. By 2024, Teleflex had evolved into a global organization with more than 14,000 employees, a diversified supply chain, and over 25 manufacturing facilities, including multiple FDA-registered sites that enhance its operational strength. A key factor contributing to Teleflex's competitive edge is its robust innovation engine. In 2024, the company increased its R&D spending by USD 7.3 million, bringing the total investment to USD 161.7 million. This highlights Teleflex's ongoing dedication to advancing catheter-related therapies and developing next-generation solutions to address evolving clinical needs.

Cardinal Health, Inc. (US) offers a wide range of medical products through its Global Medical Products and Distribution (GMPD) segment, with Foley catheters being a significant component of its urology and incontinence solutions. The company has a robust market presence, serving over 90% of hospitals in the US and 20,000 physicians’ offices and clinics, which ensures broad access to its products across more than 20 medical categories. To enhance its distribution capabilities, Cardinal Health opened a new facility in Boylston, Massachusetts, in October 2024. This expansion supports its US Medical Products and Distribution business and demonstrates its commitment to efficiency and customer reach in the Foley catheters market.

B. Braun SE (Germany) has established a strong global presence, operating in 64 countries through a network of 268 consolidated companies, along with 18 additional companies accounted for using the equity method. In 2024, the company reported a 4.4% increase in sales in its Group currency, which reflects the steady execution of its long-term growth strategy. In line with its commitment to innovation, B. Braun also increased its research and development spending by 8.6% in the same year, reaching approximately USD 572 million (EUR 526.1 million). This sustained investment underscores the company’s strategic focus on advancing product development and enhancing its position in key healthcare segments, particularly in urology and Foley catheters.

Market Ranking

The ranking of firms in the Foley catheters market is determined through market share analysis, secondary research, and validation from primary sources. This evaluation considers factors such as the breadth and depth of the product portfolio, innovation, and recent approvals or product launches.

The Foley catheters market is fragmented, with five major players collectively holding 20% to 30% of the total market share. The analysis identifies Coloplast A/S (Denmark), Becton, Dickinson and Company (US), Cardinal Health, Inc. (US), Teleflex Incorporated (US), and B. Braun SE (Germany) as the top five companies leading the market. The remaining 70% to 80% of the market is shared among various regional and emerging vendors, resulting in significant fragmentation and creating opportunities for smaller players to establish a presence.

Related Reports:

Foley Catheters Market by Insertion (Suprapubic), French Size (16Fr), Tip (Coudé), Balloon Size (5 mL), Lumen Number (2-way), Material (Silicone), Coating Type (Hydrophilic), Gender (Male), End User (Hospitals & ASCs) & Region - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com